Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Den nåværende markedsprisen på Merck & Co Inc er 1 386,86 kr, med et 24-timers handelsvolum på 7,05B kr. Eiendelens markedsverdi er 3,41T kr, etter en endring på -0.09% det siste døgnet.
Tokenisert Merck & Co Inc handles til 1 391,48 kr, med en tokenisert markedsverdi på 2,06M kr og et 24-timers handelsvolum på 2,53K kr. Den tokeniserte eiendelen har beveget seg 0.69% i løpet av de siste 24 timene.